Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 21 of the 23 sources its claims cite were checked for support.

Association of the neonatal sequential organ failure assessment score with neurological outcomes in infants diagnosed with hypoxic-ischemic encephalopathy

Open access

Abstract

Introduction: Early identification of neurodevelopmental impairment (NDI) risk in neonates with hypoxic-ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) may enable more precise care and improved outcomes. Methods: This was an exploratory, single-center, retrospective cohort study that included inborn infants admitted from January 2012- March 2023 with a diagnosis of HIE, who received TH within 6 hours of life and underwent a Weeke-scored brain MRI. Hourly neonatal sequential organ failure assessment (nSOFA) scores and laboratory maximum and minimum values were calculated using raw data. Results: Among 122 infants, 36 (29.5%) had an abnormal MRI (Weeke score ≥5). Bayley-III testing performed at ≥12 months of age was available for 66 infants, of whom 23 (34.8%) met criteria for NDI (any domain composite score <85). Models using laboratory values and the maximum nSOFA yielded good predictive accuracy for both an abnormal Weeke score (AUROC 0.79, 95% CI 0.70-0.88; NPV 81%, PPV 74%) and NDI (AUROC 0.78, 95% CI 0.66-0.89; NPV 78%, PPV 75%). Discussion: Early physiologic and laboratory measures predicted both MRI-defined injury and NDI, suggesting that early illness severity reflects underlying injury processes across outcome domains. Integration of these measures may support more precise risk stratification and prognostic assessment in infants with HIE.

Overview

CoChat Summary

TL;DR

In this single-center retrospective cohort of 122 inborn infants with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia, early laboratory/physiologic measures and the maximum nSOFA in the first 12 hours were associated with both abnormal MRI and later neurodevelopmental impairment. The authors report good predictive accuracy for models built from laboratory values plus maximum nSOFA, but they frame the work as exploratory rather than a validated clinical prediction tool.

Key findings

  • Among 122 infants, 36 (29.5%) had an abnormal Weeke MRI score (≥5), and among 66 infants with Bayley-III testing at ≥12 months, 23 (34.8%) met criteria for NDI (any domain composite score <85).
  • A model using laboratory values plus maximum nSOFA showed good predictive accuracy for abnormal Weeke score: AUROC 0.79 (95% CI 0.70–0.88), NPV 81%, PPV 74%.
  • A model using laboratory values plus maximum nSOFA also predicted NDI: AUROC 0.78 (95% CI 0.66–0.89), NPV 78%, PPV 75%.
  • MRI and Bayley classifications agreed in 62% of cases, with poor agreement beyond chance (κ = 0.14); using Bayley as reference, Weeke sensitivity was 39% and specificity 74%.

Methods

  • Exploratory, single-center, retrospective cohort study of inborn infants admitted from January 2012 to April 2023 with HIE who received therapeutic hypothermia within 6 hours of life and had a Weeke-scored brain MRI.
  • Sample included 122 infants after exclusions; 66 had Bayley-III testing at age ≥12 months. Early hourly nSOFA scores and laboratory values from birth to 12 hours of life were derived from the EHR.
  • Main analyses compared infants with and without abnormal Weeke or NDI, then used multivariable logistic regression and AUROC to assess predictive models; agreement between Weeke and Bayley was assessed with Cohen’s kappa.

Limitations

  • The paper states the study is limited by its retrospective design and that the findings “cannot be used to inform care” and should not be interpreted as a validated clinical prediction tool.
  • It also states that restricting to inborn infants reduced sample size and may limit generalizability to outborn populations, and that Bayley-III follow-up was incomplete.
  • Evident from the text: Bayley-III was available for only 66/122 infants, and 53/56 infants without Bayley testing were lost to follow-up after discharge, which may bias neurodevelopmental outcome estimates.
  • Evident from the text: the number of NDI events was limited, and the final model was restricted to three markers to reduce overfitting; the study also did not perform component-level nSOFA analyses.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fped.2026.1844058

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Hourly nSOFAindex profiles by Weeke and Bayley grouping. Individual patient nSOFAindex (running average score) trajectories for patients with a normal Weeke score (A) or abnormal Weeke score (B). (C) Hourly nSOFAindex score mean (internal line) and 95% confidence intervals (surrounding band) for the first 168 h of life by Weeke score outcome group. Individual patient nSOFAindex trajectories for patients without NDI (D) and with NDI (E). (F) Hourly nSOFAindex score mean (internal line) and 95% confidence intervals (surrounding band) for the first 168 h of life by Bayley-III score outcome group.
Figure 1 Hourly nSOFAindex profiles by Weeke and Bayley grouping. Individual patient nSOFAindex (running average score) trajectories for patients with a normal Weeke score (A) or abnormal Weeke score (B). (C) Hourly nSOFAindex score mean (internal line) and 95% confidence intervals (surrounding band) for the first 168 h of life by Weeke score outcome group. Individual patient nSOFAindex trajectories for patients without NDI (D) and with NDI (E). (F) Hourly nSOFAindex score mean (internal line) and 95% confidence intervals (surrounding band) for the first 168 h of life by Bayley-III score outcome group.CC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 1 Not valid · 1 Not checked · 55 Own results and interpretations

27 more claims

Create a free account to see all 69 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 23
  • It may state two separate claims as one. 21

Create a free account to see these claims.

Citations

Cites

Show all 22 references

Metadata

Authors
Lagnese, K., Sheth, S., Vice, S., Rajderkar, D., Roig, J. C., Weiss, M., & Wynn, J. L.
Affiliations
  • University of Florida (US)
  • Baylor College of Medicine (US)
Corresponding author
Weiss, Michael
Venue
Frontiers in Pediatrics
Published
2026-05-29
Volume
14
Pages
1844058-1844058
ISSN
2296-2360 (ISSN-L)
OpenAlex
W7162809376
Cited by
0
References
22
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Pediatrics (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Development and Preterm Care
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
Keywords
neonatal hypoxic-ischemic encephalopathy, neurodevelopmental impairment, therapeutic hypothermia, laboratory biomarkers, risk stratification, outcome prediction, Bayley-III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of the neonatal sequential organ failure assessment score with neurological outcomes in infants diagnosed with hypoxic-ischemic encephalopathy. https://app.cochat.ai/papers/10.3389/fped.2026.1844058
The paper
Lagnese, K., Sheth, S., Vice, S., Rajderkar, D., Roig, J. C., Weiss, M., & Wynn, J. L. (2026). Association of the neonatal sequential organ failure assessment score with neurological outcomes in infants diagnosed with hypoxic-ischemic encephalopathy. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2026.1844058

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.